NEUROLOGICAL OUTCOMES OF PROLONGED NEONATAL JAUNDICE IN FULL-TERM INFANTS IN ALMATY CITY
Introduction. One of the criteria for the transition of neonatal yellow sickness into a pathological condition is a duration of more than 14 days of life. Many researchers note an increase in neonatal yellow sickness and possible complications of the central nervous system in the form of child’s cerebral palsy, neuro-sensory hearing loss and behavioral disorders. The debut of diseases is possible from the neonatal period, and at an older age it significantly reduces the quality of human life.
Purpose: To study the psychomotor disorders in infants who have had prolonged neonatal yellow sickness, using the example of the neurological department of an early age of Children's City Clinical Hospital (CCCH) No. 2 in Almaty city.
Materials and research methods: In the materials of this study, a retrospective control analysis of 160 clinical records of full-term infants who were hospitalized in the neurological department of an early age of Children's City Clinical Hospital No. 2 in Almaty city since January 2016 to December 2018 was carried out. Criteria for inclusion of case in the group: full-term, resident of Almaty, age at the time of hospitalization from 0 to 12 months, the fact of prolonged yellow sickness and the level of total serum bilirubin > 85 μmol / L. Criteria for exclusion of case from the group: prematurity, absence of neonatal yellow sickness, total serum bilirubin < 85 μmol / L, a villager. Criteria for inclusion to the control group: full-term, resident of Almaty, age at the time of hospitalization from 0 to 12 months, lack of fact of transferred neonatal jaundice. Criteria for exclusion from the control group: prematurity, the presence of neonatal yellow sickness, a villager.
Results: The Mann-Whitney test between the case and control groups showed a difference only in age p = 0.018, which is associated with an earlier debut of neurological disorders in the case group. Statistically significant differences were found by the risk factors for the burden of antenatal history using the Chi-square criterion p-0,000; the following risk factors for the development of hyperbilirubinemia were established as statistically significant: incompatibility in the ABO group or Rh factor (p-0.039), delivery by caesarean section (p-0.029). Children from the case group were more likely to be hospitalized in the first three months of life (p-0,000), dyskinetic syndrome predominated in the clinic (p-0.002), they were more often diagnosed with cerebral palsy (p-0.006), and there were impaired cerebrospinal fluid dynamics according to computer and magnetic resonance imaging (p-0.006), according to routine electroencephalography there was a delay in the formation of bioelectric activity of the brain (p-0.004).
Conclusions: Neurological outcomes of protracted neonatal yellow sickness in full-term infants are presented by cerebral palsy, motor impairment in the form of a dyskinetic syndrome, pathological changes according to instrumental diagnostic methods (neurosonography, electroencephalography and computed or magnetic resonance imaging), which require further monitoring by a pediatric neurologist for long-term consequences in the second half of the first year of life and at an older age.
Zhannat V.Rakisheva¹, https://orcid.org/0000-0001-6607-5345
Marzhan M. Lepessova¹, Marat R. Rabandiyarov²
¹ Kazakh Medical University of Continuing Education (KazMUCE), Almaty, Republic of Kazakhstan;
² Children’s City Clinical Diseases Hospital No 2 , Almaty, Republic of Kazakhstan.
1. Божбанбаева Н.С. с соавт. К проблеме пролонгированных неонатальных желтух// Батыс Казакстан медицина журналы. 2015.№2(46) С.32-35
2. Боконбаева С.Дж. и Зейвальд С.В. Неонатальные патологические желтухи // Вестник КРСУ. 2019. Том 19. № 1.С.68-71
3. Зубовская Е.Т. с соавт. Современные подходы к определению содержания билирубина у новорожденных // Журнал «Медицинские новости». 2017.№2.С.15-17
4. Клинический Протокол Диагностики и Лечения РК «ДЦП» 2017.С.2 https://diseases.medelement.com.
5. Клинический Протокол Диагностики и Лечения РК «Неонатальная Желтуха». 2014. C.2. https://diseases.medelement.com.
6. Мамырбаева М.А. с соавт. Трудности мониторинга неонатальных желтух на уровне ПМСП // Батыс Казакстан медицина журналы. 2014.№4(44) С.19-21
7. Моисеева К.Е. Заболеваемость новорожденных в Российской Федерации // Медицина: теория и практика. 2019.Т.4 Спец.выпуск. С.368-369
8. Мухитдинова Х.Н. с соавт. Ультразвуковые особенности структуры головного мозга младенцев при желтухе // Вестник экстренной медицины. 2016. IX.(4). С.31-35
9. Пальчик А.Б., Шабалов Н.П. Токсические энцефалопатии новорожденных. М.:МЕДпресс-информ,2009.-160с.:ил.
10. American Academy of Paediatrics. Clinical practical Guideline. Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation // Pediatrics. Vol. No.1.July 2004. P.301 https://pediatrics.aappublications.org/content/114/1/297 (19.03.2020)
11. Cándido Corujo-Santana et al. The Relationship Between Neonatal Hyperbilirubinemia and Sensorineural Hearing Loss//Acta Otorrinolaringol Esp. 2015;66(6):P.326-331
12. Canfeng Yu. et al. Report about term infants with severe hyperbilirubinemia undergoing exchange transfusion in Southwestern China during an 11-year period, from 2001 to 2011 // PLOS ONE.2017.june.P.1-13. https://doi.org/10.1371/journal.pone.0179550
13. Elizabeth Huiwen Tham et al. Phototherapy for neonatal hyperbilirubinemia and childhood eczema, rhinitis and wheeze // Pediatrics and Neonatology (2019) 60, P.28-34 https://doi.org/10.1016/j.pedneo.2018.03.004
14. Frank R., Garfinkle J., Oskoui M., Shevell M.I. Clinical profile of children with cerebral palsy born term compared with late- and post-term: a retrospective cohort study // BJOG- An International Journal of Obstetrics and Gynaecology. 2017;124: P.1738–1745. DOI: 10.1111/1471-0528.14240
15. Ghirardello Stefano et al. Delayed Cord Clamping Increased the Need for Phototherapy Treatment in Infants With AB0 Alloimmunization Born by Cesarean Section: A Retrospective Study // Frontiers in Pediatrics.2018. Vol.6.Article 241. www.frontiersin.org
16. Hokkanen L., Launes Jy., Michelsson K.. Adult neurobehavioral outcome of hyperbilirubinemia in full term neonates—a 30 year prospective follow-up study // Peer J.2.2014:e294; P.1-20. DOI 10.7717/peerj.294
17. Hong-Tao Hu et al. Association between first caesarean delivery and adverse outcomes in subsequent pregnancy: a retrospective cohort study // BMC Pregnancy and Childbirth (2018) 18:273 https://doi.org/10.1186/s12884-018-1895-x
18. Kevin P Murphy, Susana Boutin, Kathy Ride. Cerebral palsy, neurogenic bladder, and outcomes of lifetime care// Developmental Medicine & Child Neurology 2012, 54:P. 945–950 DOI: 10.1111/j.1469-8749.2012.04360.x
19. Luo F., Chen Z., Lin H., Wang C., Ma X., Shi L. Evaluation of cerebral function in high risk term infants by using a scoring system based on aEEG//Transl Pediatriks. 2014;3(4):P.278-286
20. Ruifang Yan et al. Diagnostic value of conventional MRI combined with DTI for neonatal hyperbilirubinemia // Pediatrics and Neonatology (2018) 59, P.161-167
References:
1. Bokonbaeva S.Dzh., Zeyval'd S.V. Neonatal'nye patologicheskie zheltukhi [Neonatal pathologic jaundice]. Vestnik KRSU [Herald of KRSU]. 2019. T.19. № 1.P.68-71 [In Russian]
2. Bozhbanbaeva N.S. et al. K probleme prolongirovannykh neonatal'nykh zheltukh [On the problem of prolonged neonatal jaundice]. Batys Kazakstan meditsina zhurnaly [Medical journal of West Kazakhstan]. 2015. № 2(46) P.32-35 [In Russian]
3. Zubovskaya E.T. et al. Sovremennye podkhody k opredeleniyu soderzhaniya bilirubina u novorozhdennykh [Modern approaches to defening the content of bilirubin in newborns]. Zhurnal «Meditsinskie novosti» [Journal Meditsinskie novosti ].2017.№2. P.15-17.[In Russian]
4. Clinical protocol diagnostics and treatment of Cerebral palsy in Kazakhstan. 2017. P.2 https://diseases.medelement.com [In Russian]
5. Clinical protokol diagnostics and treatment of Neonatal jaundice in Kazakhstan. 2014. P.2 https://diseases.medelement.com [In Russian]
6. Mamyrbaeva M.A. et al. Trudnosti monitoringa neonatal'nykh zheltukh na urovne PMSP [Difficulties in monitoring of neonatal jaundice on primary health care level]. Batys Kazakstan meditsina zhurnaly [Medical journal of West Kazakstan]. 2014.№4(44) P.19-21 [In Russian]
7. Moiseeva K.E. Zabolevaemost' novorozhdennykh v Rossiyskoy Federatsii [Incidence of newborns in Russian]. Zhurnal Meditsina: teoriya i praktika [Medicine: theory and practice]. 2019.T.4 supplement. P.368-369 [In Russian]
8. Mukhitdinova Kh.N. et al. Ul'trazvukovye osobennosti struktury golovnogo mozga mladentsev pri zheltukhe [Ultrasound peculiarities of infants brain structure at jaundice].Vestnik ekstrennoy meditsiny [The bulletin of emergency medicine]. 2016. IX. (4). P.31-35 [In Russian]
9. Pal'chik A.B., Shabalov N.P. Toksicheskie entsefalopatii novorozhdennykh [The toxic neonatal encephalopathy].M.:MEDpress-inform,2009.-160s.:il. [In Russian]
10. American Academy of Paediatrics. Clinical practical Guideline. Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation //Pediatrics. Vol. No.1.July 2004. P.301 https://pediatrics.aappublications.org/content/114/1/297 (19.03.2020)
11. Cándido Corujo-Santana et al. The Relationship Between Neonatal Hyperbilirubinemia and Sensorineural Hearing Loss//Acta Otorrinolaringol Esp. 2015;66(6):P.326-331
12. Canfeng Yu et al. Report about term infants with severe hyperbilirubinemia undergoing exchange transfusion in Southwestern China during an 11-year period, from 2001 to 2011// PLOS ONE.2017.june.P.1-13. https://doi.org/10.1371/journal.pone.0179550
13. Elizabeth Huiwen Tham et al. Phototherapy for neonatal hyperbilirubinemia and childhood eczema, rhinitis and wheeze// Pediatrics and Neonatology (2019) 60, P.28-34 https://doi.org/10.1016/j.pedneo.2018.03.004
14. Frank R, Garfinkle J, Oskoui M, Shevell MI. Clinical profile of children with cerebral palsy born term compared with late- and post-term: a retrospective cohort study // BJOG- An International Journal of Obstetrics and Gynaecology. 2017;124: P.1738–1745. DOI: 10.1111/1471-0528.14240
15. Ghirardello Stefano et al. Delayed Cord Clamping Increased the Need for Phototherapy Treatment in Infants With AB0 Alloimmunization Born by Cesarean Section: A Retrospective Study// Frontiers in Pediatrics.2018. Vol.6.Article 241. www.frontiersin.org
16. Hokkanen Laura, Launes Jyrki, Michelsson Katarina. Adult neurobehavioral outcome of hyperbilirubinemia in full term neonates—a 30 year prospective follow-up study// Peer J.2.2014:e294; P.1-20. DOI 10.7717/peerj.294
17. Hong-Tao Hu et al. Association between first caesarean delivery and adverse outcomes in subsequent pregnancy: a retrospective cohort study//BMC Pregnancy and Childbirth (2018) 18:273 https://doi.org/10.1186/s12884-018-1895-x
18. Kevin P Murphy, Susana Boutin, Kathy Ride. Cerebral palsy, neurogenic bladder, and outcomes of lifetime care// Developmental Medicine & Child Neurology 2012, 54:P. 945–950 DOI: 10.1111/j.1469-8749.2012.04360.x
19. Luo F, Chen Z, Lin H, Wang C, Ma X,Shi L. Evaluation of cerebral function in high risk term infants by using a scoring system based on aEEG//Transl Pediatriks.2014;3(4):P.278-286
20. Ruifang Yan et al. Diagnostic value of conventional MRI combined with DTI for neonatal hyperbilirubinemia // Pediatrics and Neonatology (2018) 59, P.161-167
Number of Views: 192
Category of articles:
Original articles
Bibliography link
Rakisheva Zh.V., Lepessova M.M., Rabandiyarov M.R. Neurological outcomes of prolonged neonatal jaundice in full-term infants IN Almaty city // Nauka i Zdravookhranenie [Science & Healthcare]. 2020, (Vol.22) 3, pp. 89-97. doi 10.34689/SH.2020.22.3.011Related publications:
ANALYSIS OF CLINICAL AND DEMOGRAPHIC INDICATORS OF PATIENTS WITH PARKINSON'S DISEASE IN THE SOUTHERN REGION OF KAZAKHSTAN
A COMPARATIVE STUDY OF DRUG POLICY REGARDING ORPHAN DISEASES IN THE USA, THE EUROPEAN UNION, AND THE REPUBLIC OF KAZAKHSTAN
MUTATIONS IN CARDIAC ION CHANNEL GENES IN KAZAKHSTANI PATIENTS WITH LONG QT SYNDROME
GENETIC FEATURES OF CONGENITAL DYSFUNCTION OF THE ADRENAL CORTEX CAUSED BY 21-HYDROXYLASE DEFICIENCY IN PERSONS OF KAZAKH NATIONALITY
NON-MOTOR SYMPTOMS IN PARKINSON'S DISEASE USING THE EXAMPLE OF AKTOBE PATIENTS